| Patent Number |
Title Of Patent |
Date Issued |
| 6180666 |
Use of gallic acid esters to increase bioavailability of orally administered pharmaceutical comp |
January 30, 2001 |
| A method is disclosed for increasing bioavailability of an orally administered pharmaceutical compound comprising orally coadministering the pharmaceutical compound to a mammal in need of treatment with the compound and a gallic acid ester. Preferred gallic acid esters of the invention |
| 6121234 |
Use of essential oils to increase bioavailability of orally administered pharmaceutical compound |
September 19, 2000 |
| A method for increasing bioavailability and reducing inter- and intra-individual variability of an orally administered hydrophobic pharmaceutical compound, which comprises orally coadministering the pharmaceutical compound to a mammal in need of treatment with the compound with an es |
| 5962522 |
Propyl gallate to increase bioavailability of orally administered pharmaceutical compounds |
October 5, 1999 |
| A method for increasing bioavailability of an orally administered pharmaceutical compound comprises orally administering the pharmaceutical compound to a mammal in need of treatment with the compound concurrently with propyl gallate. Improved formulations of pharmaceutical compounds |
| 5916566 |
Use of benzoin gum to inhibit P-glycoprotein-mediated resistance of pharmaceutical compounds |
June 29, 1999 |
| A method for increasing bioavailabilty of an orally administered hydrophobic pharmaceutical compound, which comprises orally administering the pharmaceutical compound to a mammal in need of treatment with the compound concurrently with an essential oil or essential oil component in a |
| 5716928 |
Use of essential oils to increase bioavailability of oral pharmaceutical compounds |
February 10, 1998 |
| A method for increasing bioavailability and reducing inter- and intra-individual variability of an orally administered hydrophobic pharmaceutical compound, which comprises orally administering the pharmaceutical compound to a mammal in need of treatment with the compound concurrently |
| 5665386 |
Use of essential oils to increase bioavailability of oral pharmaceutical compounds |
September 9, 1997 |
| A method for increasing bioavailability and reducing inter- and intra-individual variability of an orally administered hydrophobic pharmaceutical compound, which comprises orally administering the pharmaceutical compound to a mammal in need of treatment with the compound concurrently |
